AHA Presidential Advisory Hospital Certification for Optimizing Cardiovascular Disease and Stroke Quality of Care and Outcomes
نویسندگان
چکیده
Cardiovascular disease and stroke remain leading causes of mortality, disability, and rising healthcare expenditures in the United States. Although a number of organizations provide hospital accreditation, recognition, and certification programs, existing programs do not address cardiovascular disease and stroke care in a comprehensive way. Current evidence suggests mixed findings for correlation between accreditation, recognition, and certification programs and hospitals’ actual quality of care and outcomes. This advisory discusses potential opportunities to develop and enhance hospital certification programs for cardiovascular disease and stroke. The American Heart Association/American Stroke Association is uniquely positioned as a patient-centered, respected, transparent healthcare organization to help drive improvements in care and outcomes for patients hospitalized with cardiovascular disease and stroke. As a part of its commitment to promoting high-quality, evidence-based care for cardiovascular and stroke patients, it is recommended that the American Heart Association/American Stroke Association explore hospital certification programs to develop truly meaningful programs to facilitate improvements in and recognition for cardiovascular disease and stroke quality of care and outcomes. Future strategies should standardize objective, unbiased assessments of hospital structural, process, and outcome performance while allowing flexibility as technology and methodology advances occur. (Circulation. 2010;122:2459-2469.)
منابع مشابه
Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes.
Cardiovascular disease and stroke remain leading causes of mortality, disability, and rising healthcare expenditures in the United States. Although a number of organizations provide hospital accreditation, recognition, and certification programs, existing programs do not address cardiovascular disease and stroke care in a comprehensive way. Current evidence suggests mixed findings for correlati...
متن کاملNew targeted AHA research program: Cardiovascular Care and Outcomes.
As noted in my Presidential Address at the 70th Scientific Sessions of the American Heart Association, cardiovascular disease and stroke remain the No. 1 and No. 3 causes of death, respectively, of all Americans. This is due in part to a gap that exists between effective interventions in clinical trials to improve patient care and outcomes and daily practice of healthcare professionals as well ...
متن کاملAHA Presidential Advisory The Importance of Population-Wide Sodium Reduction as a Means to Prevent Cardiovascular Disease and Stroke A Call to Action From the American Heart Association
Blood pressure (BP)-related diseases, specifically, stroke, coronary heart disease, heart failure, and kidney disease, are leading causes of morbidity and mortality in the United States and throughout the world. In the United States, coronary heart disease and stroke are the leading causes of mortality, whereas heart failure is the leading cause of hospitalizations.1 Concurrently, the prevalenc...
متن کاملTransitions of Care for Stroke Patients: Opportunities to Improve Outcomes.
The last 30 years have seen tremendous progress in primary and secondary stroke prevention in the United States with better control of hypertension, decreasing smoking rates, antithrombotic treatment for atrial fibrillation, use of statins, and blood transfusions for children with sickle cell disease. 1 In 1996, intravenous tissue-type plasminogen activator was approved for treatment of acute i...
متن کاملVision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers.
BACKGROUND The field of outcomes research seeks to define optimal treatment in practice and to promote the rapid full adoption of efficacious therapies into routine clinical care. The American Heart Association (AHA) formed the AHA Pharmaceutical Roundtable (PRT) Outcomes Research Centers Network to accelerate attainment of these goals. Participating centers were intended to carry out state-of-...
متن کامل